Viewing Study NCT03938792

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2026-02-04 @ 11:08 PM
Study NCT ID: NCT03938792
Status: COMPLETED
Last Update Posted: 2025-06-10
First Post: 2019-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
None Hemophilia B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Factor VIII View
None Factor IX View
None Inhibitors View
None Anti-Tissue Factor Pathway Inhibitor (TFPI) View
None Subcutaneous (sc) View
None Prophylaxis View
None On-Demand View
None BASIS View
None Inhibitor View
None SC View
None Subcutaneous View
None Injection View
None On demand View
None aTFPI View
None Anti-TFPI View
None Severe hemophilia View
None Severe bleeding View
None Hemophilia View
None PF-06741086 View
None PF 06741086 View
None Marstacimab View